The Mulligan Law Firm is Investigating Injury Claims: The Weight Loss Drugs Fen-Phen, Pondimin®
The Mulligan Law Firm is Investigating Injury Claims: The Weight Loss Drugs Fen-Phen, Pondimin® and Redux® have been Linked to Primary Pulmonary Hypertension (PPH) The Mulligan Law Firm is currently investigating injury claims involving the diet drugs Fen-Phen, Pondimin, and Redux. Withdrawn from the US market in 1997, the damage done by these drugs can be difficult to detect, even many years later. PPH can cause heart failure and death. Dallas, TX (PRWEB) October 23, 2009 -- The Mulligan Law Firm is a national law firm located in Dal
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 309
- Bankruptcy 44
- Business 134
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4